Tsuyoshi Ohta

Yamagata, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Reproductive, lifestyle, socioeconomic and anthropometric correlates of early menopause.

Reproductive, lifestyle, socioeconomic and anthropometric correlates of early menopause.

Journal: Climacteric : the journal of the International Menopause Society

Published: August 11, 2026

Clotrimazole Targets the c-Myc-Survivin Axis to Reduce the Viability of Ovarian Cancer Stem Cells Alone and in Combination with Chemotherapeutic Agents.

Clotrimazole Targets the c-Myc-Survivin Axis to Reduce the Viability of Ovarian Cancer Stem Cells Alone and in Combination with Chemotherapeutic Agents.

Journal: International journal of molecular sciences

Published: June 08, 2026

Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.

Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.

Journal: International journal of clinical oncology

Published: October 23, 2025

Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter study.

Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter study.

Journal: Journal of gynecologic oncology

Published: August 27, 2025

Senolytic Elimination of Senescent Ovarian Clear Cell Carcinoma Cells Induced by CEP-1347 With the BH3 Mimetic Navitoclax.

Senolytic Elimination of Senescent Ovarian Clear Cell Carcinoma Cells Induced by CEP-1347 With the BH3 Mimetic Navitoclax.

Journal: Anticancer research

Published: August 05, 2025

Short-Chain Fatty Acids May Promote Regulatory T Cell Induction to Enhance Maternal Immune Tolerance in Early Pregnancy.

Short-Chain Fatty Acids May Promote Regulatory T Cell Induction to Enhance Maternal Immune Tolerance in Early Pregnancy.

Journal: Reproductive sciences (Thousand Oaks, Calif.)

Published: August 01, 2025

The MDM4 Inhibitor CEP-1347 Activates Wild-type p53 in Ovarian Clear Cell Carcinoma Cells and Potently Inhibits their Growth.

The MDM4 Inhibitor CEP-1347 Activates Wild-type p53 in Ovarian Clear Cell Carcinoma Cells and Potently Inhibits their Growth.

Journal: Anticancer research

Published: June 26, 2025

Evaluation of Platinum Resistance or Sensitivity Markers by Analysis of Cell Block Specimens of Ascites Fluid in High-Grade Serous Carcinoma.

Evaluation of Platinum Resistance or Sensitivity Markers by Analysis of Cell Block Specimens of Ascites Fluid in High-Grade Serous Carcinoma.

Journal: Journal of cytology

Published: December 06, 2024

Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

Journal: Cancers

Published: October 13, 2024

Investigation of tumor mutation burden using the comprehensive genomic profiling data of vulvar and vaginal malignant tumors: an observational study using C-CAT database.

Investigation of tumor mutation burden using the comprehensive genomic profiling data of vulvar and vaginal malignant tumors: an observational study using C-CAT database.

Journal: International journal of clinical oncology

Published: September 28, 2024

Profiling of metabolic dysregulation in ovarian cancer tissues and biofluids.

Profiling of metabolic dysregulation in ovarian cancer tissues and biofluids.

Journal: Scientific reports

Published: January 25, 2024

Mechanism of Cell Death by Combined Treatment with an xCT Inhibitor and Paclitaxel: An Alternative Therapeutic Strategy for Patients with Ovarian Clear Cell Carcinoma.

Mechanism of Cell Death by Combined Treatment with an xCT Inhibitor and Paclitaxel: An Alternative Therapeutic Strategy for Patients with Ovarian Clear Cell Carcinoma.

Journal: International journal of molecular sciences

Published: June 15, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026